Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section updated to add a consolidated list of study sites across California, Colorado, District of Columbia, Florida, Georgia, Indiana, Louisiana, Maryland, Missouri, New York, North Carolina, Tennessee, Virginia, and Wisconsin. A new Revision: v3.3.3 appears and older state-specific locations and the HHS Vulnerability Disclosure link were removed (Revision: v3.3.2).
    Difference
    1%
    Check dated 2025-12-23T21:40:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added a notice that publications are automatically filled from PubMed and that the revision is v3.3.2. Removed the previous notice describing PubMed-sourced publications and the older revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the banner about government funding status and NIH operating updates; this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:52:42.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant changes detected; the page content remains the same, with only minor visual differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:10.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Page updated to v3.2.0 with a new government-operating status notice; previous version v3.1.0 reference removed. Core content remains, but timing/operational details are updated.
    Difference
    3%
    Check dated 2025-10-06T04:53:43.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page mainly updates the version tag to v3.1.0 and removes a prior version tag (v3.0.2); a reference to Dense deposit disease is also removed. No substantive changes to core content, pricing, or key entities are evident.
    Difference
    0.2%
    Check dated 2025-09-29T02:55:33.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.